The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into three programmes: 
05/08/2018
Chromos at ZKM 'Open Codes' Exhibition
Find Chromos virtual reality (VR) experience in Karlsruhe, Germany
The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into three programmes: Epigenetics, Signalling, and Lymphocyte Signalling, supported by strategic programme grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and additional funding from research councils, the EU and charities.
We maximise the impact of our research through Knowledge Exchange, Commercialisation and Public Engagement activities. We do this by collaborating with other academics, policy makers, charities, schools, the general public and industry, including companies on the Babraham Research Campus. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.
Access our Science Services
The Imaging Facility provides supported access to advanced fluorescence imaging technologies and image analysis solutions.
Our state-of-the-art Biological Support Unit provides housing and care for pathogen-free rodents used in the academic research programmes and by private companies
The Babraham Institute Flow Cytometry Core Facility offers high quality service and state-of-the-art instrumentation to members of Babraham Institute and external users.
Biological chemistry is the interface between chemistry and biology, requiring both synthetic organic chemistry skills and a knowledge of biochemistry
Providing a complete service to generate genetically altered mouse strains for Babraham Institute research groups and external companies
The Bioinformatics group provides an interface between the computational infrastructure of the institute and the biology performed within the research groups
The Mass Spectrometry Facility is housed in a purpose-built laboratory in a new building in the centre of the campus
We have established methods to analyse neutral lipids, phospholipids and sphingolipids using a Shimadzu IT-TOF mass spectrometer coupled to a Prominence HPLC system
The Facility plays a crucial role in all the Institute’s research programmes and is also available to external users on a fee-for-service basis
Academia
The following pages may be of particular interest to those in the Academic community:Correction: Epigenetic resetting of human pluripotency (doi:10.1242/dev.146811).
Guo G, von Meyenn F, Rostovskaya M
Development (Cambridge, England)
145 1477-9129: (2018)
PMID: 29669738
A Critical Role of TET1/2 Proteins in Cell-Cycle Progression of Trophoblast Stem Cells.
Chrysanthou S, Senner CE, Woods L
Stem cell reports
2213-6711: (2018)
PMID: 29576538